| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $9.13M | - | |
| Dir | 135.9K | $5.36M | - | |
| VP | 90.4K | $3.56M | -9,000 | |
| CFO | 36.7K | $1.45M | - | |
| Dir | 35.8K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sale+OE | 58,996 | $30.08 | $1,774,576.08 | -41.5% | +3.8% | +12.4% | |
| Nov 6, 2024 | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 10,471 | $29.53 | $309,168.84 | -9.5% | +6.9% | +8.2% | |
| Mar 18, 2024 | Nichols Christian Todd51 | SVP, Chief Commercial Officer | Sell | 10,417 | $28.10 | $292,739.58 | -13.6% | -9.2% | +24.8% | |
| Feb 27, 2024 | Parisi Samuel Joseph62 | VP, Finance (interim Pao) | Sale+OE | 2,559 | $29.65 | $75,874.35 | -24.9% | -20.0% | +17.2% | |
| Feb 15, 2024 | Laurencin Cato T59 | Director | Sale+OE | 2,690 | $31.85 | $85,676.50 | -15.1% | -25.9% | +10.2% | |
| Jun 8, 2023 | Laurencin Cato T59 | Director | Sale+OE | 2,638 | $31.85 | $84,020.30 | -26.1% | -6.4% | -24.2% | |
| Jun 7, 2023 | Laurencin Cato T59 | Director | Sale+OE | 2,800 | $31.50 | $88,200.00 | -27.2% | -6.0% | -22.2% | |
| May 30, 2023 | Nichols Christian Todd51 | SVP, Chief Commercial Officer | Sale+OE | 27,134 | $28.93 | $784,861.80 | -39.8% | -6.7% | -20.2% | |
| May 9, 2023 | Wysenski Nancy | Director | Sale+OE | 41,250 | $31.24 | $1,288,786.13 | -72.3% | -9.2% | -22.1% | |
| Nov 14, 2022 | Daglio David Angelo Jr. | Director | Buy | 35,000 | $23.31 | $815,734.50 | +77.8% | +21.5% | +6.1% |